Ruth Klaasen

742 total citations
26 papers, 509 citations indexed

About

Ruth Klaasen is a scholar working on Rheumatology, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ruth Klaasen has authored 26 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Rheumatology, 6 papers in Nephrology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ruth Klaasen's work include Rheumatoid Arthritis Research and Therapies (11 papers), Systemic Lupus Erythematosus Research (9 papers) and Gout, Hyperuricemia, Uric Acid (6 papers). Ruth Klaasen is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (11 papers), Systemic Lupus Erythematosus Research (9 papers) and Gout, Hyperuricemia, Uric Acid (6 papers). Ruth Klaasen collaborates with scholars based in Netherlands, Romania and Italy. Ruth Klaasen's co-authors include Carla A. Wijbrandts, Paul P. Tak, Daniëlle M. Gerlag, Arno W. van Kuijk, Rogier M. Thurlings, Dominique Baeten, P. P. Tak, T.A. Out, Jacob M. van Laar and D M Gerlag and has published in prestigious journals such as Annals of the Rheumatic Diseases, American Journal of Transplantation and Lara D. Veeken.

In The Last Decade

Ruth Klaasen

22 papers receiving 497 citations

Peers

Countries citing papers authored by Ruth Klaasen

Since Specialization

Citations

This map shows the geographic impact of Ruth Klaasen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Klaasen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Klaasen more than expected).

Fields of papers citing papers by Ruth Klaasen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Klaasen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Klaasen. The network helps show where Ruth Klaasen may publish in the future.

Co-authorship network of co-authors of Ruth Klaasen

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Klaasen. A scholar is included among the top collaborators of Ruth Klaasen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Klaasen. Ruth Klaasen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HandScan criteria versus ACR/EULAR Boolean remission as treatment target in early rheumatoid arthritis: results of a randomized controlled trial 2025 ·Rheumatology Advances in Practice ·(unknown), (unknown), Janneke Tekstra, (unknown), Ruth Klaasen, (unknown), Johannes W. G. Jacobs, (unknown), Jacob M. van Laar	0
2	Systemic and Local Medical or Surgical Therapies for Ear, Nose and/or Throat Manifestations in ANCA-Associated Vasculitis: A Systematic Literature Review 2023 ·Journal of Clinical Medicine ·(unknown), (unknown), Ruth Klaasen, (unknown), E. Christiaan Hagen, Digna M. A. Kamalski, Marloes W Heijstek, Julia Spierings	4
3	Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trial 2023 ·Annals of the Rheumatic Diseases ·(unknown), Maarten Boers, Linda Hartman, Daniela Opriș-Belinski, Reinhard Bos, Marc R. Kok, José António Pereira da Silva, E. N. Griep, Ruth Klaasen, Cornelia F Allaart, Paul Baudoin, Hennie G. Raterman, Zoltán Szekanecz, Frank Buttgereit, P. Masaryk, Willem F. Lems, Yvo M. Smulders, Maurizio Cutolo, Marieke M. ter Wee	9
4	The effect of nasal Staphylococcus aureus colonization and antibiotic treatment on disease activity in ANCA-associated vasculitis: a retrospective cohort study in the Netherlands 2022 ·Rheumatology International ·(unknown), (unknown), (unknown), Ruth Klaasen, E. Christiaan Hagen, Julia Spierings, Marloes W Heijstek	1
5	Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial 2022 ·Annals of the Rheumatic Diseases ·Maarten Boers, Linda Hartman, Daniela Opriș-Belinski, Reinhard Bos, Marc R. Kok, José António Pereira da Silva, Eduard N. Griep, Ruth Klaasen, Cornelia F Allaart, Paul Baudoin, Hennie G. Raterman, Zoltán Szekanecz, Frank Buttgereit, P. Masaryk, (unknown), Sabrina Paolino, (unknown), Willem F. Lems, Maurizio Cutolo, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	83
6	Immunosuppressive Therapies in Ear, Nose, and Throat Involvement in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Results From a Multicenter Retrospective Cohort Study 2022 ·The Journal of Rheumatology ·(unknown), (unknown), Paco M J Welsing, Ruth Klaasen, (unknown), E. Christiaan Hagen, Marloes W Heijstek, Julia Spierings	0
7	Meanderella rijsii, a new opportunist in the fungal order Pleosporales 2022 ·Microbes and Infection ·Sarah Ahmed, Tobías Engel, Jan Zoll, Peggy C. R. Godschalk, Ruth Klaasen, Leandro F. Moreno, (unknown), Paul E. Verweij, Sybren de Hoog	1
8	Medication adherence in older people with rheumatoid arthritis is lower according to electronic monitoring than according to pill count 2021 ·Lara D. Veeken ·Linda Hartman, Maurizio Cutolo, Reinhard Bos, Daniela Opriș-Belinski, Marc R. Kok, (unknown), Ruth Klaasen, Cornelia F Allaart, George A. W. Bruyn, Hennie G. Raterman, Marieke Voshaar, Nuno Gomes, Rui M. A. Pinto, (unknown), Willem F. Lems, Maarten Boers	7
9	Palmar Fasciitis and Polyarthritis Syndrome: A Rare Paraneoplastic Syndrome in a Patient With Prostate Carcinoma 2020 ·Journal of Medical Cases ·(unknown), Ruth Klaasen, Marlies C. van der Goes, Haiko J. Bloemendal	1
10	Novel optical spectral transmission (OST)-guided versus conventionally disease activity-guided treatment: study protocol of a randomized clinical trial on guidance of a treat-to-target strategy for early rheumatoid arthritis 2019 ·Trials ·(unknown), (unknown), Ruth Klaasen, (unknown), (unknown), Janneke Tekstra, (unknown), W.E. van Spil, F.P.J.G. Lafeber, A.C. Marijnissen, Jacob M. van Laar, Johannes W. G. Jacobs	6
11	The performance of dual-energy CT in the classification criteria of gout: a prospective study in subjects with unclassified arthritis 2019 ·Lara D. Veeken ·(unknown), Johannes W. G. Jacobs, (unknown), (unknown), Ben G. F. Heggelman, P.C.M. Pasker-de Jong, Jacob M. van Laar, Ruth Klaasen	8
12	Predictors of biologic-free disease control in patients with rheumatoid arthritis after stopping tumor necrosis factor inhibitor treatment 2019 ·BMC Rheumatology ·(unknown), F. Lamers-Karnebeek, Harald E. Vonkeman, Peter M. ten Klooster, Janneke Tekstra, (unknown), Ruth Klaasen, (unknown), Hein J. Bernelot Moens, Henk Visser, (unknown), Marc R. Kok, Robert Landewé, Piet L. C. M. van Riel, Mart A F J van de Laar, Tim Jansen	4
13	DCD donor hemodynamics as predictor of outcome after kidney transplantation 2018 ·American Journal of Transplantation ·Hessel Peters‐Sengers, (unknown), Martin B.A. Heemskerk, Mirza M. Idu, Robert C. Minnee, Ruth Klaasen, (unknown), (unknown), (unknown), J.J. Homan van der Heide, Joke I. Roodnat, Fréderike J. Bemelman	29
14	Gouty arthritis: decision-making following dual-energy CT scan in clinical practice, a retrospective analysis 2018 ·Clinical Rheumatology ·(unknown), Suzanne P. Linn-Rasker, (unknown), Ben G. F. Heggelman, Jacob M. van Laar, P.C.M. Pasker-de Jong, Johannes W. G. Jacobs, Ruth Klaasen	21
15	Impact of Stopping Tumor Necrosis Factor Inhibitors on Rheumatoid Arthritis Patients’ Burden of Disease 2017 ·Arthritis Care & Research ·(unknown), Peter M. ten Klooster, Harald E. Vonkeman, E. Kneepkens, Ruth Klaasen, Jan Stolk, Ilja Tchetverikov, (unknown), (unknown), Yvonne P M Goekoop-Ruiterman, Robert Landewé, Piet L. C. M. van Riel, Mart A F J van de Laar, Tim Jansen	9
16	Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis 2012 ·Annals of the Rheumatic Diseases ·Ruth Klaasen, Marieke M. J. Herenius, Carla A. Wijbrandts, Wilco de Jager, L. van Tuyl, Michael T. Nurmohamed, Berent J. Prakken, Daniëlle M. Gerlag, Paul P. Tak	42
17	Reply to the letter to the editor entitled 'Diminished clinical response to infliximab in RA patients: The role of increased soluble IL-2 receptor associated with leptin' by Dr. Ji Hong Kim and colleagues (ar-11-0371) 2011 ·Data Archiving and Networked Services (DANS) ·Ruth Klaasen, Carla A. Wijbrandts, Daniëlle M. Gerlag, Paul P. Tak	1
18	The value of rheumatoid factor and anti-citrullinated protein antibodies as predictors of response to infliximab in rheumatoid arthritis: an exploratory study 2011 ·Lara D. Veeken ·Ruth Klaasen, Tineke Cantaert, Carla A. Wijbrandts, Christine A. Teitsma, D M Gerlag, T.A. Out, (unknown), (unknown), P. P. Tak	51
19	Body mass index and clinical response to infliximab in rheumatoid arthritis 2010 ·Arthritis & Rheumatism ·Ruth Klaasen, Carla A. Wijbrandts, Daniëlle M. Gerlag, Paul P. Tak	148
20	The relationship between synovial lymphocyte aggregates and the clinical response to infliximab in rheumatoid arthritis: A prospective study 2009 ·Arthritis & Rheumatism ·Ruth Klaasen, Rogier M. Thurlings, Carla A. Wijbrandts, Arno W. van Kuijk, Dominique Baeten, Daniëlle M. Gerlag, Paul P. Tak	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact